New member John Higgins in their most recent piece examines a novel technique by the Fred Hutch Cancer Center called targeted protein degradation that could be able to overcome the shortfalls of regular inhibitors. Usually cancer medicine works by inhibiting specific cellular proteins before they can cause many issues. However, drug resistance and the difficulties of inhibition can often create barriers. Follow the story with John Higgins as he pens about the Fred Hutch team bringing a new technique to the battle against cancer – targeted protein degradation.
Photo: Linda Bartlett via Wikimedia Commons